Shilpa Medicare gains 3.5% after receiving FDA approval for an injection

Shilpa Medicare#39;s Irinotecan injection is used to treat patients with metastatic cancer of the colon or rectum.

courtsey By - https://www.moneycontrol.com/news/buzzing-stocks/shilpa-medicare-gains-35-after-receiving-fda-approval-forinjection_11899241.html